Other: Describe in Detailed Description
to assess the rate of progression to diabetes versus the rate of regression to normoglycemia along with the changes in weight and other metabolic parameters in obese non diabetic and prediabetic patients.
N/A: Not Applicable
Retrospective
N/A: Not Applicable
Case Control
Eligibility and IRB
Both
Min:
18
Max:
Yes
No
(200) normoglyemic and pre-diabetic obese patients on Liraglutide, or on metformin followed up by Dr. AZAR since January 2008 Group 1: on Liraglutide and group 2 : on metformin